Published: 9 February 2024
Author(s): Kunal Mahajan, Lakshmi Nagendra, Anil Dhall, Deep Dutta
Issue: May 2024
Section: Original Article

Patients with acute coronary syndrome (ACS) are at maximal risk of recurrent events in the initial few weeks following the index coronary event, with some studies suggesting that the risk may be as high as 20 % [1]. Rapid reduction of low-density lipoprotein cholesterol (LDL-C) has been shown to reduce disease progression, reduce the risk of future ischemic events, lower morbidity and mortality in these patients [2]. Consequently, all major global guidelines recommend the in-hospital initiation of high-intensity statin therapy to prevent these early ischemic events [3].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.